Team:Paris Bettencourt/SebaTemplate
From 2013.igem.org
Line 292: | Line 292: | ||
</div> | </div> | ||
</a> | </a> | ||
- | <a | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/TB_France" title="TB in France"> |
<div class="subpanel5"> | <div class="subpanel5"> | ||
<img class="narrowimg" src="https://static.igem.org/mediawiki/2013/3/39/PB_TBinFrance.png" width="354px" height="156px"/> | <img class="narrowimg" src="https://static.igem.org/mediawiki/2013/3/39/PB_TBinFrance.png" width="354px" height="156px"/> | ||
Line 302: | Line 302: | ||
</div> | </div> | ||
</a> | </a> | ||
- | <a | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/TB_Gallery" title="TB Gallery"> |
<div class="subpanel5" style="margin-bottom:0;height:158px;"> | <div class="subpanel5" style="margin-bottom:0;height:158px;"> | ||
<img class="narrowimg" src="https://static.igem.org/mediawiki/2013/2/2f/PB_TBgallery%281%29.png" width="354px" height="156px"/> | <img class="narrowimg" src="https://static.igem.org/mediawiki/2013/2/2f/PB_TBgallery%281%29.png" width="354px" height="156px"/> | ||
Line 314: | Line 314: | ||
</div> | </div> | ||
<div class="subpanel4"> | <div class="subpanel4"> | ||
- | <a | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/Gender_Study" title="Gender Study"> |
<div class="subpanel7"> | <div class="subpanel7"> | ||
<img class="narrowimg" src="https://static.igem.org/mediawiki/2013/8/8c/Gender.png" width="354px" height="283px"/> | <img class="narrowimg" src="https://static.igem.org/mediawiki/2013/8/8c/Gender.png" width="354px" height="283px"/> | ||
Line 324: | Line 324: | ||
</div> | </div> | ||
</a> | </a> | ||
- | <a | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/Technology_Transfer" title="Technology Transfer" style="margin-top:11px"> |
<div class="subpanel9"> | <div class="subpanel9"> | ||
<img class="narrowimg" src="https://static.igem.org/mediawiki/2013/3/3c/TB_knowledge.png" width="354px" height="283px"/> | <img class="narrowimg" src="https://static.igem.org/mediawiki/2013/3/3c/TB_knowledge.png" width="354px" height="283px"/> | ||
Line 335: | Line 335: | ||
</a> | </a> | ||
</div> | </div> | ||
- | <div | + | <div style="margin-right:0;width:356px"> |
<a class="subpanel6" href="https://2013.igem.org/Team:Paris_Bettencourt/Collaboration" title="Collaboration"> | <a class="subpanel6" href="https://2013.igem.org/Team:Paris_Bettencourt/Collaboration" title="Collaboration"> | ||
<div class="subpanel6"> | <div class="subpanel6"> | ||
Line 346: | Line 346: | ||
</div> | </div> | ||
</a> | </a> | ||
- | <a | + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/SensiGEM" title="SensiGEM"> |
<div class="subpanel6" style="margin-bottom:0"> | <div class="subpanel6" style="margin-bottom:0"> | ||
<img class="narrowimg" src="https://static.igem.org/mediawiki/2013/d/d5/TB_senigem.png" width="354px" height="283px"/> | <img class="narrowimg" src="https://static.igem.org/mediawiki/2013/d/d5/TB_senigem.png" width="354px" height="283px"/> |
Revision as of 12:37, 14 October 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB: from gene detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins. Click this panel to see our project overview.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
Infiltrate macrophages with an E.coli producing TDMH, an enzyme that will lyse the Mycobacteria cell wall.